← All Sponsors
SPONSOR

University of Texas Southwestern Medical Center

Total Trials
30
Recruiting
30
Phases
Phase 2, EARLY_Phase 1, Phase 4

University of Texas Southwestern Medical Center is a clinical research sponsor with 30 registered studies on ClinicalTrials.gov, of which 30 are actively recruiting participants. Research covers conditions including Lipid Metabolism Disorder, Bladder Cancer, Urothelial Carcinoma, Hematuria.

The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Texas Southwestern Medical Center

How many clinical trials has University of Texas Southwestern Medical Center sponsored?
ClinicalMetric currently tracks 30 clinical trials sponsored by University of Texas Southwestern Medical Center, of which 30 are actively recruiting participants. These trials cover conditions including Lipid Metabolism Disorder, Bladder Cancer, Urothelial Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Texas Southwestern Medical Center research focus on?
University of Texas Southwestern Medical Center clinical trials span Lipid Metabolism Disorder, Bladder Cancer, Urothelial Carcinoma, Hematuria, Smoking Cessation, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Texas Southwestern Medical Center clinical trial?
To participate in a University of Texas Southwestern Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Texas Southwestern Medical Center trials with current recruitment status updated daily.

Clinical Trials by University of Texas Southwestern Medical Center

NCT05693701
Recruiting

Multicomponent Intervention Study- Blood Donors With High Cholesterol

Lipid Metabolism Disorder
NCT05646485
Recruiting

Bladder Cancer Screening Trial

Bladder Cancer
NCT06593314
Recruiting

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

Heart Failure
NCT07170657
Recruiting

Teen Recovery Through Inspiration, Support, and Empowerment

Suicidal Ideation
NCT07689175 Phase 2
Recruiting

Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)
NCT07292792
Recruiting

The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services

HIV Disease
NCT06966336
Recruiting

IEEM- Work:Rest Cycles in Burn Survivors- Humidity

Hyperthermia
NCT06467708
Recruiting

Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury

TBI (Traumatic Brain Injury)
NCT06400550
Recruiting

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

Melanoma (Skin)
NCT06789848 Phase 2
Recruiting

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Advanced Hepatocellular Carcinoma
NCT07352709
Recruiting

Ventilation Performance and Feedback Simulation Trial

Out-of-hospital Cardiac Arrest (OHCA)
NCT05028309
Recruiting

Effects of Obesity in the Aged

Obesity
NCT07032389 Phase 2
Recruiting

A Polypill for Acute Coronary Syndrome

Acute Coronary Syndrome
NCT05106036
Recruiting

Preventing Cognitive Decline by Reducing BP Target Trial

Cognitive Decline
NCT06076538
Recruiting

PET/MR for Characterization of Renal Masses (RMs)

Renal Tumor
NCT06266338 Phase 2
Recruiting

Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)

Cervix Cancer
NCT04838678 EARLY_Phase 1
Recruiting

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Hypertension
NCT07430761
Recruiting

ET Stigma Response to Tremor Suppression

Action Tremor
NCT05478694
Recruiting

Outcomes of Focal Ablation for Prostate Cancer

Prostate Cancer
NCT03872102
Recruiting

Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging

Parkinson Disease
NCT07426016
Recruiting

Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration

Respiratory Distress Syndrome (Neonatal)
NCT07183644
Recruiting

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

Port Wine Stains
NCT05886816 Phase 2
Recruiting

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

SARS-CoV Infection
NCT07494812
Recruiting

Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials

NPH (Normal Pressure Hydrocephalus)
NCT03621553 Phase 4
Recruiting

Vitamin D Homeostasis in Sarcoidosis

Sarcoidosis
NCT04232631
Recruiting

Non-Invasive Testing to Evaluate Wound Healing in Diabetes

Diabetic Foot Ulcer
NCT00992303
Recruiting

Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Unspecified Adult Solid Tumor, Protocol Specific
NCT07113353
Recruiting

Non-Invasive ICP Monitoring Study

Intracranial Pressure
NCT04623502
Recruiting

An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

Kidney Cancer
NCT06130059 Phase 2
Recruiting

Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

Heart Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology